Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE: rhPTH(1-84) for Symptomatic Hypoparathyroidism
NCT03324880Phase 4Completed
- Sponsor
- Takeda
- Start
- Jan 2018
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 4 trial of parathyroid hormone 1-84 in hypoparathyroidism, sponsored by Takeda. Started Jan 2018; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT03324880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324880.